Sales & Marketing News | pharmaphorum

News

Australia's CSL makes $11.7bn bid for Swiss pharma Vifor

Australian biotech group CSL has agreed a deal to acquire Swiss drugmaker Vifor Pharma in an all-cash deal that expands its speciality medicines business.

News

AbbVie prices first presbyopia drug Vuity at $80 per month

AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects.

News

Shkreli's former company pays $40m in price-gouging settleme...

A pharma company formerly led by 'pharma bro' Martin Shkreli has settled a long-running lawsuit with the US federal government over massive price increases for an off-patent drug treatment

News

Did AZ scupper Sobi's $8bn private equity buyout?

An $8 billion attempt by two private equity companies to acquire Swedish rare disease specialist Sobi and take it back into private ownership has collapsed, with reports suggesting AstraZen

News

UK government rubberstamps millions of extra COVID vaccines

The UK government has placed a 114 million-dose order with Pfizer/BioNTech and Moderna – sufficient to provide two doses to every person in Britain – in a bid to future-proof against COVID-

News

China's insulin plans will hit 2022 revenues, says Novo Nord...

Novo Nordisk has said that the introduction of value-based procurement (VBP) for insulin products by the Chinese government will have an impact on its revenues next year.

Australia's CSL makes $11.7bn bid for Swiss pharma Vifor

AbbVie prices first presbyopia drug Vuity at $80 per month

Shkreli's former company pays $40m in price-gouging settleme...

Did AZ scupper Sobi's $8bn private equity buyout?

UK government rubberstamps millions of extra COVID vaccines

China's insulin plans will hit 2022 revenues, says Novo Nord...

On the benefits of earlier oncological intervention, with Jo...

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks